Sexual Victimization and Somatic Complaints in Pregnancy: Examination of Depression as a Mediator.

H. Littleton

DOI: https://doi.org/10.1016/j.whi.2015.06.013

2015-11-01

Abstract:

What problem does this paper attempt to address?

Are Psychotherapies for Young People Growing Stronger? Tracking Trends Over Time for Youth Anxiety, Depression, Attention-Deficit/Hyperactivity Disorder, and Conduct Problems

John R. Weisz,Sofie Kuppens,Mei Yi Ng,Rachel A. Vaughn-Coaxum,Ana M. Ugueto,Dikla Eckshtain,Katherine A. Corteselli

DOI: https://doi.org/10.1177/1745691618805436

2018-12-20

Perspectives on Psychological Science

Abstract:With the development of empirically supported treatments over the decades, have youth psychotherapies grown stronger? To investigate, we examined changes over time in treatment effects for four frequently treated youth mental-health problems: anxiety, depression, attention-deficit hyperactivity disorder (ADHD), and conduct disorders. We used PubMed and PsycINFO to search for randomized controlled trials (RCTs) that were published between January 1960 and May 2017 involving youths between the ages of 4 and 18 years. We also searched reviews and meta-analyses of youth psychotherapy research, followed reference trails in the reports we identified, and obtained additional studies identified by therapy researchers whom we contacted. We identified 453 RCTs (31,933 participants) spanning 53 years (1963–2016). Effect sizes for the problem-relevant outcome measures were synthesized via multilevel meta-analysis. We tracked temporal trends for each problem domain and then examined multiple study characteristics that might moderate those trends. Mean effect size increased nonsignificantly for anxiety, decreased nonsignificantly for ADHD, and decreased significantly for depression and conduct problems. Moderator analyses involving multiple study subgroups showed only a few exceptions to these surprising patterns. The findings suggest that new approaches to treatment design and intervention science may be needed, especially for depression and conduct problems. We suggest intensifying the search for mechanisms of change, making treatments more transdiagnostic and personalizable, embedding treatments within youth ecosystems, adapting treatments to the social and technological changes that alter youth dysfunction and treatment needs, and resisting old habits that can make treatments unduly skeuomorphic.

psychology, multidisciplinary
Evidence-Based Psychosocial Treatments for Children and Adolescents With Attention Deficit/Hyperactivity Disorder

Steven W. Evans,Julie Sarno Owens,Brian T. Wymbs,A. Raisa Ray

DOI: https://doi.org/10.1080/15374416.2017.1390757

2017-12-19

Abstract:The purpose of this research was to update the series of articles on evidence-based treatment for children and adolescents with attention deficit/hyperactivity disorder that have appeared in this journal (Evans, Owens & Bunford, 2014; Pelham & Fabiano, 2008; Pelham, Wheeler, & Chronis, 1998). We completed a systematic review of the literature published between 2012 and 2016 to establish levels of evidence for psychosocial treatments for these youth. We identified articles using criteria established by the Society of Clinical Child and Adolescent Psychology using keyword searches of abstracts and titles. Articles were classified according to a modified version of the Division 12 task force guidelines that was used in other reviews in this series. The results revealed that findings are becoming increasingly nuanced with variations in levels of evidence related to ages of the children and characteristics of the specific treatment. In addition, we focused our critique on generalization of treatment effects across settings and time and on sample diversity (with regard to ethnicity and levels of parent education) in relation to the population. Children of parents with higher levels of education than average appear to be overrepresented in the literature. Implications for future treatment development and evaluation and for dissemination research are discussed.

psychology, clinical, developmental
Evidence Base Update: 50 Years of Research on Treatment for Child and Adolescent Anxiety

Charmaine K. Higa-McMillan,Sarah E. Francis,Leslie Rith-Najarian,Bruce F. Chorpita

DOI: https://doi.org/10.1080/15374416.2015.1046177

2015-06-18

Abstract:Anxiety disorders are the most common mental health disorder among children and adolescents. We examined 111 treatment outcome studies testing 204 treatment conditions for child and adolescent anxiety published between 1967 and mid-2013. Studies were selected for inclusion in this review using the PracticeWise Evidence-Based Services database. Using guidelines identified by this journal (Southam-Gerow & Prinstein, 2014), studies were included if they were conducted with children and/or adolescents (ages 1-19) with anxiety and/or avoidance problems. In addition to reviewing the strength of the evidence, the review also examined indicators of effectiveness, common practices across treatment families, and mediators and moderators of treatment outcome. Six treatments reached well-established status for child and adolescent anxiety, 8 were identified as probably efficacious, 2 were identified as possibly efficacious, 6 treatments were deemed experimental, and 8 treatments of questionable efficacy emerged. Findings from this review suggest substantial support for cognitive-behavioral therapy (CBT) as an effective and appropriate first-line treatment for youth with anxiety disorders. Several other treatment approaches emerged as probably efficacious that are not primarily CBT based, suggesting that there are alternative evidence-based treatments that practitioners can turn to for children and adolescents who do not respond well to CBT. The review concludes with a discussion of treatments that improve functioning in addition to reducing symptoms, common practices derived from evidence-based treatments, mediators and moderators of treatment outcomes, recommendations for best practice, and suggestions for future research.

psychology, clinical, developmental
Evidence Base Update of Psychosocial Treatments for Child and Adolescent Depression

V. Robin Weersing,Megan Jeffreys,Minh-Chau T.,Karen T. G. Schwartz,Carl Bolano,Minh-Chau T. Do

DOI: https://doi.org/10.1080/15374416.2016.1220310

2016-11-21

Abstract:Depression in youth is prevalent and disabling and tends to presage a chronic and recurrent course of illness and impairment in adulthood. Clinical trial research in youth depression has a 30-year history, and evidence-based treatment reviews appeared in 1998 and 2008. The current review of 42 randomized controlled trials (RCTs) updates these reviews to include RCTs published between 2008 and 2014 (N = 14) and reevaluates previously reviewed literature. Given the growing maturity of the field, this review utilized a stringent set of methodological criteria for trial inclusion, most notable for excluding trials based in subclinical samples of youth that had been included in previous reviews (N = 12) and including well-designed RCTs with null and negative findings (N = 8). Findings from the current review suggest that evidence for child treatments is notably weaker than for adolescent interventions, with no child treatments achieving well-established status and the evidentiary basis of treatments downgraded from previous reports. Cognitive behavioral therapy (CBT) for clinically depressed children appears to be possibly efficacious, with mixed findings across trials. For depressed adolescents, both CBT and interpersonal psychotherapy are well-established interventions, with evidence of efficacy in multiple trials by independent investigative teams. This positive conclusion is tempered by the small size of the interpersonal psychotherapy literature (N = 6) and concern that CBT effects may be attenuated in clinically complicated samples and when compared against active control conditions. Data on predictors, moderators, and mediators are examined and priorities for future research discussed.

psychology, clinical, developmental
The Future of Child and Adolescent Clinical Psychopharmacology: A Systematic Review of Phase 2, 3, or 4 Randomized Controlled Trials of Pharmacologic Agents Without Regulatory Approval or for Unapproved Indications

Samuele Cortese,Katherine McGinn,Mikkel Højlund,Alan Apter,Celso Arango,Immaculada Baeza,Tobias Banaschewski,Jan Buitelaar,Josefina Castro-Fornieles,David Coghill,David Cohen,Edna Grünblatt,Anthony James,Pia Jeppesen,Péter Nagy,Anne Katrine Pagsberg,Mara Parellada,Diane Purper-Ouakil,Veit Roessner,Paramala Santosh,Emily Simonoff,Dejan Stevanovic,Argyris Stringaris,Benedetto Vitiello,Susanne Walitza,Abraham Weizman,Tamar Wohlfarth,Ian C K Wong,Gil Zalsman,Alessandro Zuddas,Carmen Moreno,Marco Solmi,Pieter J. Hoekstra,Antonio M. Persico,Christoph U. Correll

DOI: https://doi.org/10.1016/j.neubiorev.2023.105149

2023-03-31

Abstract:The pace of development and implementation of novel medications in child and adolescent psychiatry has remained slow. We systematically searched https://clinicaltrials.gov/ and https://www.clinicaltrialsregister.eu/ (from 01/01/2010 to 08/23/2022) for phase 2 or 3 randomized controlled trials (RCTs) of medications without regulatory approval in the US, Europe or Asia. We also included RCTs of dietary interventions/probiotics. Additionally, we searched phase 4 RCTs of agents targeting unlicensed indications for children/adolescents with mental health disorders. We retrieved 234 ongoing or completed RCTs, including 26 (11%) with positive findings on ≥1 primary outcome, 43 (19%) with negative/unavailable results on every primary outcome, and 165 (70%) without publicly available statistical results. The only two compounds with evidence of significant effects that were replicated in ≥1 additional RCT without any negative RCTs were dasotraline for attention-deficit/hyperactivity disorder, and carbetocin for hyperphagia in Prader-Willi syndrome. Among other strategies, targeting specific symptom dimensions in samples stratified based on clinical characteristics or established biomarkers may increase chances of success in future development programmes.

behavioral sciences,neurosciences
Toward a Level Playing Field: Predictive Factors for the Outcomes of Mental Health Treatment for Adolescents

SUSAN D. PHILLIPS,MICHAEL B. HARGIS,TERESA L. KRAMER,SHELLY Y. LENSING,J. LYNN TAYLOR,BARBARA J. BURNS,JAMES M. ROBBINS

DOI: https://doi.org/10.1097/00004583-200012000-00008

2000-12-01

Abstract:OBJECTIVE: To understand better the effectiveness of routine treatment for emotional and behavioral problems experienced by adolescents, methods are needed to control for between-provider differences in the distribution of factors that adversely affect treatment success. Such methods are necessary to fairly compare providers' outcomes and to aid clinicians in identifying adolescents for whom routine care may need to be altered. As a preliminary step toward developing a model to adjust treatment outcomes to account for predictive factors, findings from studies of treated samples of adolescents were reviewed to identify the factors that influence the likelihood of treatment success for this population.METHOD: Medline and PSYCInfo databases were searched for studies of treated adolescents that reported the association between expert-nominated predictive factors and outcomes. Thirty-four studies met inclusion criteria.RESULTS: Significant predictors identified in these studies include diagnosis, baseline severity of symptoms and functional impairment, family dysfunction, and previous treatment. Several expert-nominated factors have not been adequately studied in treated samples.CONCLUSIONS: Much basic work is needed before a convincing body of empirical evidence can explain predictive factors for adolescent mental health treatment outcomes. Future efforts should determine a reduced set of predictive factors that can be measured with minimal burden to providers.

pediatrics,psychiatry,psychology, developmental
Trends in Child and Adolescent Mental Health Research and its Countermeasures

Yuan Liu,Yijuan Zhong

DOI: https://doi.org/10.54097/ijeh.v11i1.12746

2023-10-16

International Journal of Education and Humanities

Abstract:The mental health issues among children and adolescents have become a focal point of attention in today's society. This paper reviews and analyzes the current trends in research on the mental health of children and adolescents. The results indicate that future research will exhibit characteristics of interdisciplinary collaboration, technological applications, and innovative psychological intervention strategies. To promote overall improvement in the mental health of children and adolescents, it is necessary to enhance the qualifications of professionals, provide social support, and establish collaborative networks. By implementing these measures, we can create a better psychological environment for children and adolescents.
Evidence-Based Psychosocial Treatments for Phobic and Anxiety Disorders in Children and Adolescents

Wendy K. Silverman,Armando A. Pina,Chockalingam Viswesvaran

DOI: https://doi.org/10.1080/15374410701817907

2008-03-03

Abstract:The article reviews psychosocial treatments for phobic and anxiety disorders in youth. Using criteria from Nathan and Gorman (2002), 32 studies are evaluated along a continuum of methodological rigor. In addition, the treatments evaluated in each of the 32 studies are classified according to Chambless et al.'s (1996) and Chambless and Hollon's (1998) criteria. Findings from a series of meta-analyses of the studies that used waitlists also are reported. In accordance with Nathan and Gorman, the majority of the studies were either methodologically robust or fairly rigorous. In accordance with Chambless and colleagues, although no treatment was well-established, Individual Cognitive Behavior Therapy, Group Cognitive Behavior Therapy (GCBT), GCBT with Parents, GCBT for social phobia (SOP), and Social Effectiveness Training for children with SOP each met criteria for probably efficacious. The other treatments were either possibly efficacious or experimental. Meta-analytic results revealed no significant differences between individual and group treatments on diagnostic recovery rates and anxiety symptom reductions, as well as other youth symptoms (i.e., fear, depression, internalizing and externalizing problems). Parental involvement was similarly efficacious as parental noninvolvement in individual and group treatment formats. The article also provides a summary of the studies that have investigated mediators, moderators, and predictors of treatment outcome. The article concludes with a discussion of the clinical representativeness and generalizability of treatments, practice guidelines, and future research directions.

psychology, clinical, developmental
The Second Special Issue on Evidence-Based Psychosocial Treatments for Children and Adolescents: A 10-Year Update

Wendy K. Silverman,Stephen P. Hinshaw

DOI: https://doi.org/10.1080/15374410701817725

2008-03-03

Abstract:This introduction to the Second Special Issue on Evidence-Based Psychosocial Treatments for Children and Adolescents provides background information on the development of this 10-year update and explains how this issue expands on the initial special issue on “empirically supported psychosocial treatments” published in 1998. The introduction also provides a summary of the contents of the present issue and the information covered in the articles contained herein. Also summarized are the criteria used to evaluate the level of evidence for each treatment, as well as the criteria used to evaluate the methodological rigor of the studies that are reviewed. The introduction concludes with comments about the advances that have been made in the past decade, with the hope that this second special issue will serve to stimulate further research and expansion of the evidence base for child and adolescent psychosocial treatments to ameliorate youth clinical problems.

psychology, clinical, developmental
Behavioral Activation as a Principle-Based Treatment: Developments from a Multi-Site Collaboration to Advance Adolescent Depression Treatment

Jessica L. Jenness,Kathryn DeLonga,R. Eric Lewandowski,Carolyn Spiro,Katherine Crowe,Christopher R. Martell,Kenneth E. Towbin,Argyris Stringaris,Elizabeth McCauley

DOI: https://doi.org/10.1080/23794925.2022.2042871

2022-03-23

Abstract:Adolescent depression is a serious and debilitating disorder associated with lifelong negative outcomes, including heightened risk for recurrence into adulthood, psychiatric comorbidities, and suicide. Among evidence-based treatments for adolescents, psychotherapies for depression have the smallest effect sizes of all psychiatric conditions studied. Advancing care for depression in adolescents is complex due to the heterogeneity in etiology and co-occurring difficulties among youth presenting with depression symptoms. This and a companion paper (Lewandowski et al., 2022) draw on a recent multisite collaboration that focused on implementing depression treatment for adolescents within clinical and research contexts. Specifically, this paper will review our work adapting behavioral activation (BA) as a principle-based framework to improve effectiveness and efficiency of depression treatment used within clinical and research settings in academic medical centers. Piloted adaptations include the use of BA principles to address idiographic drivers of depression and in-session BA "exposures" to illustrate BA principles. Case vignettes illustrate these adaptations of BA to address adolescent depression in the context of co-occurring difficulties.
Trends in Mental Disorders in Children and Adolescents Receiving Treatment in the State Mental Health System

Ramin Mojtabai,Mark Olfson

DOI: https://doi.org/10.1016/j.jaac.2024.08.008

2024-08-26

Abstract:Objective: To examine recent trends in clinical diagnoses of children and adolescents receiving treatment in publicly funded mental health treatment services in the United States. Method: Data on children and adolescents (≤17 years) receiving treatment from publicly funded mental health treatment services recorded in Mental Health Client Level Data (MH-CLD) 2013-2021 (total number of records=13,684,154) were used to examine temporal trends in the proportion of different child and adolescent psychiatric disorders. Trends were examined overall and in age, sex, racial/ethnic and service strata focusing on community-based programs. Results: The analyses revealed increases in the proportion with anxiety disorders from 9.6% in 2013 to 19.2% in 2021, AOR=2.17, 95% CI=1.85-2.55, p<0.001, trauma- and stressor-related disorders from 22.7% to 27.4%, AOR=1.31, 1.09-1.57, p=0.004, and depressive disorders from 13.4% to 17.0%, AOR=1.20, 1.03-1.41, p=0.04. During this same period, the proportion with bipolar disorders declined almost eight-fold from 10.0% to 1.3%; AOR=0.07, 0.06-0.09, p<0.001. The proportion with conduct disorders also declined from 9.7% to 4.4%; AOR=0.42, 0.32-0.55, p<0.001, and the proportion of oppositional-defiant disorder declined from 11.1% to 7.8%; AOR=0.79, 0.65-0.98, p=0.03. Trends varied across sex, age, and racial/ethnic strata. Conclusion: The composition of childhood psychiatric diagnoses in patients within publicly funded mental health settings changed over the past decade. While some of the trends may reflect changes in diagnostic practices of clinicians, increases in anxiety and depressive disorders parallel trends in the prevalence of these conditions in the general population and highlight a growing need for identifying and treating these conditions in this age group.
Practitioner Review: Therapeutics of unipolar major depressions in adolescents

Ian M Goodyer,Paul O Wilkinson

DOI: https://doi.org/10.1111/jcpp.12940

Abstract:Background: Over the past two decades new and key randomized controlled trials have reported the efficacy, clinical and cost effectiveness of psychological and pharmacological treatments for adolescents with major depression. Methods: The literature was searched through pubmed, psychinfo, scopus and web of science for randomized controlled trials of current major depression together with meta-analyses and systematic reviews of trials between 2000 and 2017. Those specific to the adolescent years (11-18 years) were taken as the primary source for this narrative review. Additional selected studies in adults were used to illustrate methodological issues. Results: Manualized psychological therapies and the SSRI fluoxetine are more effective than active placebo in the treatment of major depressions. Mild to moderate illnesses attending community-based services are likely to benefit from psychological treatment alone. Moderately to severely ill patients attending clinic and hospital services are likely to benefit from monotherapies or combining psychological and pharmacological treatment. Antidepressants carry a small but significant side-effect risk including increased suicidality. Side effects from psychotherapies are somewhat lower but specific negative consequences remain less well characterized. There is some evidence that CBT-based approaches prevent onset of major depression episode in well adolescents at high-risk. Other psychological interventions have not been adequately studied. There has been only limited identification of treatment moderators and no clear understanding of therapeutic mechanisms. Conclusions: There is now a range of clinically effective treatments for depressed adolescents. Future research needs to reveal moderators of and mechanisms for individual differences to treatment response, determine psychotherapies of value for milder depressions, enhance our understanding of safety and side-effects for all treatments, and consider how to reduce and treat treatment-resistant cases.
Daniel Gerdeaux (ed.), Gestion piscicole des grands plans d'eau (Fish Management in Large Water Bodies)

R. Billard

DOI: https://doi.org/10.1023/A:1020331818648

2004-11-28

Reviews in Fish Biology and Fisheries

Abstract:
Family-based treatment research: a 10-year update.

G. Diamond,A. Josephson

DOI: https://doi.org/10.1097/01.CHI.0000169010.96783.4E

2005-09-01

Abstract:OBJECTIVE To provide an update on the state of the art of family-based treatment research. METHOD Randomized clinical trials conducted in the past 10 years that included parents as a primary participant in treatment of child and adolescent psychiatric problems were reviewed. Studies were identified from major literature search engines (e.g., PsycINFO, Medline). Current significant pilot work was identified in the National Institute of Mental Health Computer Retrieval of Information on Scientific Projects (CRISP) Web page or from the authors themselves. RESULTS Family treatments have proven effective with externalizing disorders, particularly conduct and substance abuse disorders, and in reducing the comorbid family and school behavior problems associated with attention-deficit/hyperactivity disorder. Several new studies suggest that family treatments or treatment augmented by family treatments are effective for depression and anxiety. CONCLUSIONS For many disorders, family treatments can be an effective stand-alone intervention or an augmentation to other treatments. Engaging parents in the treatment process and reducing the toxicity of a negative family environment can contribute to better treatment engagement, retention, compliance, effectiveness, and maintenance of gains. Recommendations for the next decade of research and some implications of family-based treatment for child and adolescent psychiatry are explored.

Psychology,Medicine
Evidence-based long term interventions targeting acute mental health presentations for children and adolescents: systematic review

Brigitte Gerstl,Bright Opoku Ahinkorah,Thomas P. Nguyen,James Rufus John,Patrick Hawker,Teresa Winata,Febe Brice,Michael Bowden,Valsamma Eapen

DOI: https://doi.org/10.3389/fpsyt.2024.1324220

IF: 4.7

2024-03-07

Frontiers in Psychiatry

Abstract:Background: Long term intervention services have proven to be effective in improving mental health (MH) outcomes and the quality of life for children and young people (CYP). Aim: To synthesize evidence on the effectiveness of long-term interventions in improving MH outcomes for CYP, 0-17 years, presenting with MH conditions. Methods: A systematic search was carried out and the methodological quality of included long term MH intervention studies were assessed. Six databases were searched for peer-reviewed articles between January 2000 and September 2022. Results: We found 30 studies that reported on the effectiveness of a range of long-term MH interventions in the form of (i) group therapy, (ii) multisystemic behavior therapy, (iii) general services, (iv) integrated services, (v) psychotherapy, (vi) intensive intervention services, (vii) comprehensive collaborative care, (viii) parent training, and (ix) home outreach service. Among the included studies, seven were rated as high level of evidence based on the National Health and Medical Research Council (NHMRC) levels of evidence hierarchy scale and seven were of moderate quality evidence. Others were rated as lower-quality evidence. Among the studies providing high quality evidence, most were reported for group therapy, general services, and psychotherapy studies demonstrating beneficial effects. Conclusion: This systematic review provides evidence to demonstrate the benefits of a range of long-term interventions, in a range of settings, can be effective in improving MH outcomes for CYP and their families. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42022323324.

psychiatry
Evidence-Based Psychosocial Treatments for Self-Injurious Thoughts and Behaviors in Youth

Catherine R. Glenn,Joseph C. Franklin,Matthew K. Nock

DOI: https://doi.org/10.1080/15374416.2014.945211

2014-09-25

Abstract:The purpose of this study was to review the current evidence base of psychosocial treatments for suicidal and nonsuicidal self-injurious thoughts and behaviors (SITBs) in youth. We reviewed major scientific databases (HealthSTAR, MEDLine, PsycINFO, PubMed) for relevant studies published prior to June 2013. The search identified 29 studies examining interventions for suicidal or nonsuicidal SITBs in children or adolescents. No interventions currently meet the Journal of Clinical Child and Adolescent Psychology standards for Level 1: well-established treatments. Six treatment categories were classified as Level 2: probably efficacious or Level 3: possibly efficacious for reducing SITBs in youth. These treatments came from a variety of theoretical orientations, including cognitive-behavioral, family, interpersonal, and psychodynamic theories. Common elements across efficacious treatments included family skills training (e.g., family communication and problem solving), parent education and training (e.g., monitoring and contingency management), and individual skills training (e.g., emotion regulation and problem solving). Several treatments have shown potential promise for reducing SITBs in children and adolescents. However, the probably/possibly efficacious treatments identified each have evidence from only a single randomized controlled trial. Future research should focus on replicating studies of promising treatments, identifying active treatment ingredients, examining mediators and moderators of treatment effects, and developing brief interventions for high-risk periods (e.g., following hospital discharge).

psychology, clinical, developmental
Charting a course for empowered adolescent substance use treatment.

Elisa M. Trucco,Sarah A. Hartmann,Nilofar Fallah-Sohy

DOI: https://doi.org/10.1037/cps0000219

2024-06-04

Clinical Psychology Science and Practice

Abstract:Comments on an article by S. N. Meisel et al. (see record 2022-61172-001), which provides a critical update to a prior systematic review focused on mechanisms of behavior change (MOBC) in adolescent substance use (SU) treatment. The present authors offer some additional considerations regarding how and for whom adolescent SU treatments are most efficacious. First, they propose other notable mediators that could be leveraged given the unique cognitive flexibility, prosocial contexts, and motivations that characterize adolescence from a strengths-based perspective. Second, they examine how diverse racial/ethnic backgrounds of adolescents can impact the effectiveness of SU treatments while offering unique MOBC for consideration. Lastly, they note subgroups that could influence which SU treatment components are most relevant based on etiological pathways. (PsycInfo Database Record (c) 2024 APA, all rights reserved)

psychology, clinical
Practitioner Review: Treatments for young people who self-harm - challenges and recommendations for research and clinical practice

Katrina Witt,Anne Stewart,Keith Hawton

DOI: https://doi.org/10.1111/jcpp.14052

2024-08-28

Abstract:Background: Self-harm is very common in young people and is associated with suicide. Rates of both self-harm and suicide have increased in young people, particularly in females. There is a clear need to identify new approaches to prevent repeat self-harm. Method: We significantly update and build on previous reviews with the aim of identifying issues in research relevant to clinical practice. We identify challenges in developing, implementing and evaluating treatments for self-harm in children and adolescents, suggest a way forward for research, and provide clear and practical guidance for clinicians on how to apply current research evidence in the real world. Results: Currently, there is limited evidence for effective interventions, other than some support for dialectical behaviour therapy for adolescents (DBT-A). To improve research and, by extension, clinical practice, future studies need to address psychosocial factors associated with youth self-harm and suicide, investigate the critical mechanism(s) of action, ensure trials are sufficiently powered and representative, and involve young people more actively in the design, implementation and evaluation of these approaches. Consideration should also be given to alternative research designs, such as pragmatic or adaptive clinical trials, as well as registry-based randomised controlled trials which leverage administrative data collected in routine clinical practice, to help meet these goals. Conclusions: Recommendations for practice include undertaking comprehensive assessment and formulation, and offering DBT-A where indicated. There should be further development and evaluation (with input from young people) of Cognitive Behavioural-based Therapy adapted for young people. Greater attention to the role of the therapeutic relationship and family involvement (where possible) is also an important considerations, irrespective of the specific therapeutic modality. Finally, more consideration should be given to improving staff training to ensure all clinical staff feel equipped to treat young people who self-harm in a person-centred and compassionate manner.
A Second and Third Look at FIRST: Testing Adaptations of A Principle-Guided Youth Psychotherapy

Evelyn Cho,Sarah Kate Bearman,Rebecca Woo,John R. Weisz,Kristin M. Hawley

DOI: https://doi.org/10.1080/15374416.2020.1796678

2020-08-07

Abstract:We examined the acceptability, integrity, and symptom trajectories associated with FIRST, a principle-guided treatment for youth internalizing and externalizing problems designed to support efficient uptake and implementation.We conducted two open trials of an adapted FIRST, focusing on uptake and implementation by novice trainees in a university-affiliated clinic, limiting treatment duration to six sessions, and benchmarking findings against a 2017 FIRST trial with community therapists. In Study 1, trainees received a two-day training and weekly two-hour supervision (N = 22 youths, ages 7–17, 50% female, 54.54% Caucasian, 4.55% Latinx). In Study 2, trainees received a one-day training and weekly one-hour supervision, delivering the six-session FIRST in a predetermined sequence (N = 26 youths, ages 11–17, 42.31% female, 65.38% Caucasian, 7.69% Latinx). In Study 3, the original study therapists – now practitioners – evaluated FIRST's effectiveness and implementation difficulty, and reported their own post-study FIRST use.Acceptability (treatment completion, session attendance, caregiver participation) and integrity (adherence, competence) were comparable across Study 1, Study 2 and the 2017 trial. Improvement effect sizes across ten outcome measures were in the large range in all three trials: M ES = 1.10 in the 2017 trial, 0.83 in Study 1, and 0.81 in Study 2. Study 3 showed high effectiveness ratings, low difficulty ratings, and continued use of FIRST by a majority of clinicians.Across two open trials and a follow-up survey, FIRST showed evidence of acceptability and integrity, with youth symptom reduction comparable to that in prior research.

psychology, clinical, developmental
Common practical questions - and answers - at the British Association for Psychopharmacology child and adolescent psychopharmacology course

Samuele Cortese,Frank Mc Besag,Bruce Clark,Chris Hollis,Joseph Kilgariff,Carmen Moreno,Dasha Nicholls,Paul Wilkinson,Marc Woodbury-Smith,Aditya Sharma

DOI: https://doi.org/10.1177/02698811221140005

Abstract:The British Association for Psychopharmacology course on child and adolescent psychopharmacology has been run for more than 20 years and is currently a very popular course, attracting around 140 delegates/year from across the United Kingdom and abroad. As Faculty of recent sessions of the course, we have selected the most common questions we have been asked in recent years and provided evidence-based and/or expert-informed answers. We have included 27 questions and answers related to attention-deficit/hyperactivity disorder, anxiety and depressive disorders, autism spectrum disorder, bipolar disorder, eating disorders, epilepsy (in differential diagnosis or comorbid with mental health conditions), obsessive-compulsive disorder, personality disorders, psychotic spectrum disorders, and tics/Tourette syndrome in children and young people. We hope that this article will be helpful for prescribers in their daily clinical practice and we look forward to further, high-level evidence informing the answers to these and other questions in child and adolescent psychopharmacology.

Sexual Victimization and Somatic Complaints in Pregnancy: Examination of Depression as a Mediator.

Are Psychotherapies for Young People Growing Stronger? Tracking Trends Over Time for Youth Anxiety, Depression, Attention-Deficit/Hyperactivity Disorder, and Conduct Problems

Evidence-Based Psychosocial Treatments for Children and Adolescents With Attention Deficit/Hyperactivity Disorder

Evidence Base Update: 50 Years of Research on Treatment for Child and Adolescent Anxiety

Evidence Base Update of Psychosocial Treatments for Child and Adolescent Depression

The Future of Child and Adolescent Clinical Psychopharmacology: A Systematic Review of Phase 2, 3, or 4 Randomized Controlled Trials of Pharmacologic Agents Without Regulatory Approval or for Unapproved Indications

Toward a Level Playing Field: Predictive Factors for the Outcomes of Mental Health Treatment for Adolescents

Trends in Child and Adolescent Mental Health Research and its Countermeasures

Evidence-Based Psychosocial Treatments for Phobic and Anxiety Disorders in Children and Adolescents

The Second Special Issue on Evidence-Based Psychosocial Treatments for Children and Adolescents: A 10-Year Update

Behavioral Activation as a Principle-Based Treatment: Developments from a Multi-Site Collaboration to Advance Adolescent Depression Treatment

Trends in Mental Disorders in Children and Adolescents Receiving Treatment in the State Mental Health System

Practitioner Review: Therapeutics of unipolar major depressions in adolescents

Daniel Gerdeaux (ed.), Gestion piscicole des grands plans d'eau (Fish Management in Large Water Bodies)

Family-based treatment research: a 10-year update.

Evidence-based long term interventions targeting acute mental health presentations for children and adolescents: systematic review

Evidence-Based Psychosocial Treatments for Self-Injurious Thoughts and Behaviors in Youth

Charting a course for empowered adolescent substance use treatment.

Practitioner Review: Treatments for young people who self-harm - challenges and recommendations for research and clinical practice

A Second and Third Look at FIRST: Testing Adaptations of A Principle-Guided Youth Psychotherapy

Common practical questions - and answers - at the British Association for Psychopharmacology child and adolescent psychopharmacology course